Home
Conditions
Secondary Acute Myeloid Leukemia

Clinical trial condition

Secondary Acute Myeloid Leukemia

Explore clinical trials studying Secondary Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

117 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Secondary Acute Myeloid Leukemia trial results

Completed

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

NCT04620681

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Veliparib and Temozolomide in Treating Patients With Acute Leukemia

NCT01139970

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +45 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

NCT01760655

Conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, +61 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

NCT00357565

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Nivolumab and Azacitidine With or Without Ipilimumab in Treating Patients With Refractory/Relapsed or Newly Diagnosed Acute Myeloid Leukemia

NCT02397720

Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia

NCT02658487

Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Multilineage Dysplasia, +14 more
Locations: Yale University New Haven, Connecticut, United States

Medical University of South Carolina Hollings Cancer Center Charleston, South Carolina, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02085408

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States

University of Arizona Health Sciences Center Tucson, Arizona, United States

View all 269 locations

View Trial Details

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02642965

Conditions: Acute Myeloid Leukemia Post Cytotoxic Therapy, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Kaiser Permanente Downey Medical Center Downey, California, United States

View all 73 locations

View Trial Details

Completed

Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02299518

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +14 more
Locations: The State Ohio University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Secondary Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia trial results

Related conditions